Abstract
HTLV-1 virus infection and the molecular mechanisms associated with lymphomagenesis in ATLL are scarce. Although it takes six decades of latent viral infection until the development of T lymphoproliferative neoplasia, there is no biological marker that can be used in the clinical and laboratory monitoring of asymptomatic carriers of HTLV-1. Carriers who acquired HTLV-1 via the vertical ro…